News for Healthier Living

Bridging Diagnosis and Therapy: Advances in Radionuclide Conjugate Drugs

Radionuclide drug conjugates (RDCs) have emerged as transformative agents that integrate diagnosis and therapy into a single clinical workflow. By coupling radioactive isotopes with antibodies, peptides, or small molecules, RDCs enable precise tumor targeting, high diagnostic sensitivity, and effective localized radiotherapy.

December 22, 2025


January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025

December 30 2025

December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025